TODD BACA: Open Payments
NPI 1720763451 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 28 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $750 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $161 |
| Actelion Pharmaceuticals US, Inc. | 1 | $101 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| Lilly USA, LLC | 3 | $67 |
| TOLMAR, INC. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Exact Sciences Corporation | 2 | $39 |
| PFIZER INC. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $28 |
Products named: VRAYLAR, UPTRAVI, JARDIANCE, JATENZO, SHINGRIX, BREZTRI, Cologuard Collection Kit, Rybelsus.
Industry payments across CA — which companies pay providers there.
